Helena Wiklund-Jernberg

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.

Journal: Cancer research

Published: June 28, 2022

One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.

One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.

Journal: Epigenomes

Published: July 14, 2021

The miR-125a and miR-320c are potential tumor suppressor microRNAs epigenetically silenced by the polycomb repressive complex 2 in multiple myeloma.

The miR-125a and miR-320c are potential tumor suppressor microRNAs epigenetically silenced by the polycomb repressive complex 2 in multiple myeloma.

Journal: RNA & disease (Houston, Tex.)

Published: July 01, 2017

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains.

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains.

Journal: Oncotarget

Published: February 14, 2017

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.

Journal: Oncotarget

Published: October 09, 2016

SUMO-modified insulin-like growth factor 1 receptor (IGF-1R) increases cell cycle progression and cell proliferation.

SUMO-modified insulin-like growth factor 1 receptor (IGF-1R) increases cell cycle progression and cell proliferation.

Journal: Journal of cellular physiology

Published: October 02, 2016

A Role for the Chromatin-Remodeling Factor BAZ1A in Neurodevelopment.

A Role for the Chromatin-Remodeling Factor BAZ1A in Neurodevelopment.

Journal: Human mutation

Published: December 30, 2015

Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.

Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.

Journal: Oncotarget

Published: June 03, 2015

Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2--implications for a combinatorial treatment.

Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2--implications for a combinatorial treatment.

Journal: Oncotarget

Published: December 30, 2014

Growth signals employ CGGBP1 to suppress transcription of Alu-SINEs.

Growth signals employ CGGBP1 to suppress transcription of Alu-SINEs.

Journal: Cell cycle (Georgetown, Tex.)

Published: December 09, 2014

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.

Journal: The Journal of experimental medicine

Published: October 23, 2014

Taming the cancer cell.

Taming the cancer cell.

Journal: Journal of internal medicine

Published: June 20, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026